Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07243652

I-DECIDE After Bronchiolitis Hospitalization

Although automatic follow-up is a nearly universal practice, research has shown that these visits are often unnecessary after hospitalizations caused by bronchiolitis. Despite endorsement by national pediatric authorities, robust evidence, and family enthusiasm for as-needed (PRN) follow-up, it remains substantially underutilized for children hospitalized for bronchiolitis.

The goal of I-DECIDE is to compare the effects of two multi-component implementation strategies, both of which aim to (a) increase PRN follow-up prescribing by hospitalists (physicians who care for hospitalized children) and (b) decrease unnecessary follow-up visit attendance by families.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Bronchiolitis Acute

Age range

0 month–24 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's of Alabama, Birmingham, Alabama, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary diagnosis of bronchiolitis, discharged by a generalist inpatient service from a non-ICU, non-emergency department, non-step down unit

Exclusion criteria

  • Children with a history of gestational age <28 weeks, chronic lung disease, complex or hemodynamically significant heart disease, immunodeficiency, or neuromuscular disease
  • Children being discharged with home oxygen therapy

Treatment and study plan

Moderate-Resource Implementation Strategy

Other

The moderate-resource implementation strategy includes educational outreach (including family-facing materials to support follow-up decision making), audit and feedback (review of clinician performance, captured in a structured report), and materials for clinical decision support.

High-Resource Implementation Strategy

Other

The high-resource implementation strategy includes all of the moderate resource components, plus two forms of external facilitation: small-group facilitation and expert clinical decision support coach-led facilitation. In total, the high-resource implementation strategy includes educational outreach (including family-facing materials to support follow-up decision-making), audit and feedback (review of clinician performance, captured in a structured report), materials for clinical decision support, small-group facilitation and expert clinical decision support coach-led facilitation.

Primary outcomes

  1. Adoption

    Time frame: Within 7 days of hospital discharge

    Proportion of participants who are prescribed PRN follow-up

Secondary outcomes

  1. Sustainment

    Time frame: Within 7 days of hospital discharge

    Proportion of participants who attend a follow-up visit

Study contacts

Contact information is provided by the study sponsor or research team.

Chris Bonafide, MD, MSCE

CONTACT

[email protected]

Eric Coon, MD, MS

CONTACT

[email protected]

206-884-1223

Sponsors and collaborators

Lead sponsor

Seattle Children's Hospital

Other

Collaborators

  • Children's Hospital of Philadelphia
  • Patient-Centered Outcomes Research Institute

Registry information

Official study title

Cluster Randomized Trial of a Moderate vs High Resource Implementation Strategy to Increase As-needed Post-hospitalization Follow-up for Children With Bronchiolitis

Acronym: I-DECIDE

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Nov 24, 2025
Registry last updated
Feb 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.